National Health Investors, Inc.
NHI
$84.07
-$3.61-4.12%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 271.60M | 267.10M | 268.24M | 263.73M | 257.05M |
| Total Other Revenue | 107.69M | 90.47M | 82.36M | 79.89M | 78.54M |
| Total Revenue | 379.29M | 357.57M | 350.60M | 343.62M | 335.58M |
| Cost of Revenue | 70.50M | 58.11M | 52.77M | 54.55M | 53.88M |
| Gross Profit | 308.79M | 299.47M | 297.82M | 289.07M | 281.71M |
| SG&A Expenses | 29.53M | 27.75M | 26.35M | 24.17M | 21.79M |
| Depreciation & Amortization | 80.94M | 77.97M | 75.52M | 73.10M | 71.44M |
| Other Operating Expenses | 1.08M | 850.00K | 689.00K | 493.00K | 37.00K |
| Total Operating Expenses | 182.06M | 164.68M | 155.34M | 152.31M | 147.15M |
| Operating Income | 197.23M | 192.90M | 195.26M | 191.31M | 188.43M |
| Income Before Tax | 140.79M | 145.77M | 141.54M | 139.80M | 136.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 140.79 | 145.77 | 141.54 | 139.80 | 136.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.39M | 1.49M | 1.40M | 1.41M | 1.35M |
| Net Income | 142.18M | 147.26M | 142.93M | 141.20M | 137.99M |
| EBIT | 197.23M | 192.90M | 195.26M | 191.31M | 188.43M |
| EBITDA | 278.18M | 270.87M | 270.78M | 264.41M | 259.88M |
| EPS Basic | 3.03 | 3.19 | 3.15 | 3.17 | 3.14 |
| Normalized Basic EPS | 1.87 | 1.83 | 1.88 | 1.88 | 1.86 |
| EPS Diluted | 3.02 | 3.17 | 3.13 | 3.15 | 3.12 |
| Normalized Diluted EPS | 1.87 | 1.82 | 1.87 | 1.87 | 1.85 |
| Average Basic Shares Outstanding | 187.50M | 184.96M | 181.01M | 177.71M | 175.38M |
| Average Diluted Shares Outstanding | 188.21M | 185.76M | 182.12M | 178.86M | 176.41M |
| Dividend Per Share | 2.72 | 3.62 | 3.60 | 3.60 | 3.60 |
| Payout Ratio | 119.36% | 112.14% | 112.99% | 112.29% | 113.43% |